Bovine Mastitis companies

  • Report ID: 4647
  • Published Date: Apr 23, 2025
  • Report Format: PDF, PPT

Companies Dominating the Bovine Mastitis Landscape

    • Boehringer Ingelheim International GmbH
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Zoetis Inc.
    • Merck & Co., Inc.
    • Ceva Santé Animale
    • Nimrod Veterinary Products Ltd
    • Bayer AG
    • ImmuCell Corporation
    • West Way Health
    • Neogen Corporation
    • Forte Healthcare Ltd.

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

Bovine Mastitis Market in 2025 is estimated at USD 2.45 billion.

The global market size was over USD 2.31 billion in 2024 and is anticipated to witness a CAGR of around 7.5%, crossing USD 5.91 billion revenue by 2037.

North America is expected to hit USD 2.01 billion by 2037, supported by the rising prevalence of bovine mastitis and dairy industry expansion.

The major players in the market include Boehringer Ingelheim International GmbH, Zoetis Inc., Merck & Co., Inc., Ceva Santé Animale, Nimrod Veterinary Products Ltd, Bayer AG, ImmuCell Corporation, West Way Health, Neogen Corporation, Forte Healthcare Ltd.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos